Document Detail


Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain.
MedLine Citation:
PMID:  21035225     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
OBJECTIVES: primary aim: to determine the degree of control of HbA(1c) at the time of treatment intensification (TI) in T2DM patients. Secondary aims: fasting plasma glucose levels; estimation of the elapsed time between HbA(1c) exceeding 7% and TI; antidiabetic combinations used, % patients with good cardiometabolic control (LDL-c<100mg/dL; SBP<130 and DPB<80mmHg and HbA(1c)<7%).
RESEARCH DESIGN AND METHODS: one-cohort, multicenter, retrospective, observational study conducted in Spain. Patients diagnosed with T2DM that had switched from monotherapy to combination antidiabetic therapy were evaluated at baseline and after one year of follow-up.
RESULTS: a total of 1202 T2DM patients were analyzed. At the time of TI: mean HbA(1c) 8.1%; median time of uncontrolled disease: 2.0 years. After one-year of TI: significant reduction in mean HbA(1c) (8.1% vs.7.0%, p<0.001) and a mean fasting plasma glucose levels reduction (181.1mg/dL vs.144.1mg/dL, p<0.001) was also observed. The percentage of patients under glycemic control (HbA(1c)<7%) increased from 12.2% to 51.6% (p<0.001). Most common antidiabetic combinations: metformin+sulfonylurea (44.1%) and metformin+thiazolidindione (15.9%).
CONCLUSIONS: in the population of T2DM patients analyzed, TI was carried out when HbA(1c) values were above those recommended in clinical guidelines (≤ 7%), with a delay of two years to address the second step of therapy, despite the consensus recommendation of the ADA/EASD of 3 months. TI was shown to be effective since addition of a second antidiabetic drug led to an average reduction of HbA(1c) of approximately 1%. Metformin was the drug most commonly used as monotherapy being the most frequent combination metformin+sulfonylurea.
Authors:
Pedro Conthe; Manuel Mata; Domingo Orozco; Francisco Pajuelo; Carmen Sofía Barreto; Silvia Fernández Anaya; Ramón Gomis
Related Documents :
2809505 - Early determination of serum lipids and apolipoproteins in acute myocardial infarction:...
20353425 - Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-ind...
6420965 - Long-term treatment of onchocerciasis patients from the liberian rain-forest with low d...
20921085 - Steroids and statins: an old and a new anti-inflammatory strategy compared.
17214755 - The effectiveness of implementing a bladder ultrasound programme in neurosurgical units.
15308865 - Surgical treatment of pancreatic fistula.
Publication Detail:
Type:  Journal Article     Date:  2010-10-29
Journal Detail:
Title:  Diabetes research and clinical practice     Volume:  91     ISSN:  1872-8227     ISO Abbreviation:  Diabetes Res. Clin. Pract.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8508335     Medline TA:  Diabetes Res Clin Pract     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  108-14     Citation Subset:  IM    
Copyright Information:
2010 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Hospital Gregorio Marañón, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Validation of a stochastic modelling approach for Listeria monocytogenes growth in refrigerated food...
Next Document:  Assessing treatment barriers in young adults with type 1 diabetes.